This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

A New Mutual Fund for Rough Markets

Hartch often takes names that have fallen out of favor. He recently bought Bed Bath & Beyond (BBBY), a retailer that dominates its niche. Last year the shares sank from around $74 to $55 as investors worried that Amazon.com (AMZN) would steal away sales. Hartch remains confident that Bed Bath & Beyond can keep its customers. "We have a high regard for the business," he says. "The fact that others had some concerns created an opportunity for us," he says.

Hartch cites Google (GOOG) as a favorite holding that is in both funds. The leading search company will remain dominant because it is a cost-effective vehicle for advertisers, says Hartch. "It would be extremely difficult for competitors to unseat Google," he says.

Both funds also own Novartis (NVS), the Swiss health care giant. The company has a long record for developing innovative products and selling them around the globe, says Hartch. The Swiss multinational's Alcon line has been generating growing sales by producing contact lenses and medicines for eyes.

The global BBH fund recently bought Pearson (PSO), a U.K. publisher that supplies books and online services to educational institutions. The company is struggling to make the transition from print to the digital world. But Hartch argues that Pearson ranks as a global education leader. "Demand will remain strong because schools in the U.S. and Europe need to achieve better outcomes at lower costs," he says.

This article is commentary by an independent contributor, separate from TheStreet's regular news coverage.

Stan Luxenberg is a freelance writer specializing in mutual funds and investing. He was executive editor of Individual Investor magazine.
2 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG
AAPL $129.62 -2.20%
FB $79.34 -1.50%
GOOG $532.32 -1.44%
TSLA $247.46 -0.11%
YHOO $42.85 -1.46%

Markets

DOW 18,041.54 -190.48 -1.04%
S&P 500 2,104.20 -21.86 -1.03%
NASDAQ 5,032.7510 -56.6110 -1.11%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs